Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

COVID Symptoms and COVID Anxiety in Sickle Cell Disease

Wally R Smith, MD, Benjamin Jaworowski, BS, Shirley Johnson, BA, LSW, Thokozeni Lipato, MD, Daniel M Sop, BS,MS

Blood (2020) 136 (Supplement 1): 16–17.

https://doi.org/10.1182/blood-2020-143054

Published: 2020

Journal Articles

Early Initiation of Treatment with Rivipansel for Acute Vaso-Occlusive Crisis in Sickle Cell Disease (SCD) Achieves Earlier Discontinuation of IV Opioids and Shorter Hospital Stay: Reset Clinical Trial Analysis

Carlton D. Dampier, MD, Marilyn J. Telen, MD, Ted Wun, MD, Wally R Smith, MD, R. Clark Brown, MD PhD, Payal Desai, MD, Fuad A El Rassi, MD, Julie Kanter, MD, Beng R. Fuh, MD, Yves D. Pastore, MD, Jennifer A. Rothman, MD, James G. Taylor, MD, David Readett, BM, BS, MRCP, Jay N Lozier, MDPhD, John L. Magnani, PhD, Helen M Thackray, MD, Kathryn L. Hassell, MD

Blood (2020) 136 (Supplement 1): 18–19.

https://doi.org/10.1182/blood-2020-134803

Published: 2020

Journal Articles

The Effect of Crizanlizumab on the Number of Days Requiring Opioid Use for Management of Pain Associated with Vaso-Occlusive Crises in Patients with Sickle Cell Disease: Results from the Sustain Trial

Wally R Smith, MD, Kenneth I. Ataga, MD, Santosh L. Saraf, MD, Olufolake A. Adisa, MDMSc, Miranda Bailey, Nicholas Ramscar, MBBS, Ashley Bonner, PhD, Stephen Brown, PhD, Laura Pastor, MSc

Blood (2020) 136 (Supplement 1): 32–33.

https://doi.org/10.1182/blood-2020-140428

Published: 2020

Journal Articles

Improvement in the Clinical Global Impression of Change with Voxelotor in Patients with Sickle Cell Disease in the Phase 3 HOPE Trial

Wally R Smith, MD, Jane S. Hankins, MD MS, Miguel R Abboud, MD, Ze Cong, PhD, Jonathan Sorof, MD, Sarah Gray, PhD, Carolyn Hoppe, MD, Paul Telfer, DM, FRCP

Blood (2020) 136 (Supplement 1): 5–6.

https://doi.org/10.1182/blood-2020-137121

Published: 2020

Journal Articles

Improved Utilization Amongst Adult Sickle Cell Disease Patients: A Multi-Disciplinary Medical Home Approach

Daniel Sop, BS,MS, Shirley Johnson, BA, LSW, Benjamin Jaworowski, BS, Wally R Smith, MD

Blood (2020) 136 (Supplement 1): 22–23.

https://doi.org/10.1182/blood-2020-143001

Published: 2020

Journal Articles

Severity Classification for Sickle Cell Disease: A RAND/UCLA Modified Delphi Panel

Nirmish Shah, David Beenhouwer, Michael S Broder, MD MSHS, Lanetta Bronte-Hall, Laura De Castro, MD MHSc, Sarah N Gibbs, Victor R Gordeuk, MD, Julie Kanter, MD, Elizabeth S Klings, MD, Thokozeni Lipato, MD, Deepa Manwani, MD, Brigid Scullin, Irina Yermilov, Wally R Smith, MD

Blood (2019) 134 (Supplement_1): 415.

https://doi.org/10.1182/blood-2019-121556

Published: 2019

Journal Articles

Development and Validation of a Functional Status-Based Pain Assessment Tool

Margaret Guy, MD, Rehan Qayyum, MD, Pamela Derby, RN, FNP-BC, Nicole Carter, RN, MSN, NP-C, Jessica Keiser, MD, Alexandra Ulbing, BS, Daniel Sop, BS,MS, Wally R Smith, MD

Blood (2019) 134 (Supplement_1): 416.

https://doi.org/10.1182/blood-2019-131315

Published: 2019

Journal Articles

The Effect of Patient Navigators on Health-Related Quality of Life in Sickle Cell Anemia: The SHIP-HU Study

Wally R Smith, MD, Donna k McClish, PhD, Shirley Johnson, BA, LSW, Richard Lottenberg, MD, India Sisler, MD, Daniel Sop, BS,MS, Anthony Villella, MD, Darla K Liles, MD, Elizabeth Yang, MD PhD, Ian Chen, MD

Blood (2019) 134 (Supplement_1): 2168.

https://doi.org/10.1182/blood-2019-131266

Published: 2019

Journal Articles

Case Management Featuring Community Health Workers Reduces Inpatient Health Care Utilization in Adults with Sickle Cell Disease

Wally R Smith, MD, Daniel Sop, BS,MS, Shirley Johnson, BA, LSW, Thokozeni Lipato, MD, Mica Ferlis, ANP, Caitlin Mcmanus, ANP, Margaret Guy, MD, Sarah Hartigan, MD, Emily Holt, BS, Chantal McHenry, BS, John D. Roberts, MD

Blood (2019) 134 (Supplement_1): 2104.

https://doi.org/10.1182/blood-2019-130441

Published: 2019

Journal Articles

Tiered Oral Therapy Protocol for Sickle Cell Vaso-Occlusive Crisis

Margaret Guy, MD, Lauren Magee, PharmD, BCPS, Jessica Keiser, MD, Nicole Carter, RN, MSN, NP-C, DaleMarie Vaughan, PharmD, BCPS, Chantal McHenry, BS, Daniel Sop, BS,MS, Sarah Hartigan, MD, Wally R Smith, MD

Blood (2019) 134 (Supplement_1): 3446.

https://doi.org/10.1182/blood-2019-131298

Published: 2019

Journal Articles

Using Lean Six Sigma to Develop a Patient Centered Medical Home for Adults with Sickle Cell Disease

Shirley Johnson, BA, LSW, Sarah Hartigan, MD, Emily Holt, BS, Daniel Sop, BS,MS, Chantal McHenry, BS, Thokozeni Lipato, MD, Taylor Elliott, MA, Mica Ferlis, ANP, Caitlin Mcmanus, ANP, Wally R Smith, MD

Blood (2019) 134 (Supplement_1): 3408.

https://doi.org/10.1182/blood-2019-131117

Published: 2019

Journal Articles

Crizanlizumab Versus Placebo, with or without Hydroxyurea/Hydroxycarbamide, in Adolescent and Adult Patients with Sickle Cell Disease and Vaso-Occlusive Crises: A Randomized, Double-Blind, Phase III Study (STAND)

Miguel R. Abboud, MD, Jo Howard, MB, BChir, Rodolfo Cançado, Wally R Smith, MD, Birol Güvenç, MD, Noemi Espurz, Marine Weill, Mariane de Montalembert, MD PhD

Blood (2019) 134 (Supplement_1): 998.

https://doi.org/10.1182/blood-2019-125775

Published: 2019

Journal Articles

Responsivity of Utilization Rates to the Intensity of Case Management over Time Among High-Utilizing Adults with Sickle Cell Disease

Wally R Smith, MD, Daniel Sop, BS,MS, Shirley Johnson, BA, LSW, Thokozeni Lipato, MD, Sarah Hartigan, MD

Blood (2019) 134 (Supplement_1): 5803.

https://doi.org/10.1182/blood-2019-128259

Published: 2019

Journal Articles

The Effect of Patient Navigators on Laboratory Parameters of Hydroxyurea Adherence in Sickle Cell Anemia: The SHIP-HU Study

Wally R Smith, MD, Donna k McClish, PhD, Richard Lottenberg, MD, India Sisler, MD, Daniel Sop, BS,MS, Shirley Johnson, BA, LSW, Anthony Villella, MD, Darla K Liles, MD, Elizabeth Yang, MD PhD, Ian Chen, MD

Blood (2019) 134 (Supplement_1): 2309.

https://doi.org/10.1182/blood-2019-131201

Published: 2019

Journal Articles

The Association of Painful Crises with Patient Reported Outcomes in Sickle Cell Disease: The SHIP-HU Study

Donna k McClish, PhD, Wally R. Smith, MD, Victoria Okhomiuna, MS, PhD, Daniel Sop Mouaffo, BS, MS, Richard Lottenberg, MD, Ian Chen, MD, India Sisler, MD, Shirley Johnson, BA, LSW, Darla K Liles, MD, Elizabeth Yang, MD PhD, Thokozeni Lipato, MD

Blood (2018) 132 (Supplement 1): 3509.

https://doi.org/10.1182/blood-2018-99-114869

Published: 2018

Journal Articles

Defining Sickle Cell Disease Acute Painful Episodes: The Pisces Project

Donna k McClish, PhD, Wally R. Smith, MD, Joshua J. Field, MD, Samir K. Ballas, MD, Claudia M Campbell, PhD, Lori E. Crosby, PhD, Carlton Dampier, MD, Deepika S. Darbari, MD, William Zempsky, MD

Blood (2018) 132 (Supplement 1): 3510.

https://doi.org/10.1182/blood-2018-99-114830

Published: 2018

Journal Articles

Development of a Framework to Describe Roles and Responsibilities for Sickle Cell Community Health Workers

Joan Corder-Mabe, RN, MS, Shirley Johnson, BA, LSW, Wally R. Smith, MD, Daniel Sop Mouaffo, BS, MS, Thokozeni Lipato, MD

Blood (2018) 132 (Supplement 1): 5831.

https://doi.org/10.1182/blood-2018-99-114944

Published: 2018

Journal Articles

Access to Care, and Emergency Department Utilization for Adults and Adolescents with Sickle Cell Disease: Ascq-Me and the SHIP-HU Study

Wally R. Smith, MD, Donna k McClish, PhD, Richard Lottenberg, MD, India Sisler, MD, Thokozeni Lipato, MD, Ian Chen, MD, Shirley Johnson, BA, Ding-Yu Fei, PhD, Daniel Sop Mouaffo, MS

Blood (2017) 130 (Supplement 1): 2257.

https://doi.org/10.1182/blood.V130.Suppl_1.2257.2257

Published: 2017

Journal Articles

Comparison of Adult and Adolescent Quality of Ambulatory and Emergency Care in Sickle Cell Disease: Ascq-Me and the SHIP-HU Study

Wally R. Smith, MD, Donna k McClish, PhD, Richard Lottenberg, MD, Ian Chen, MD, Marsha J. Treadwell, PhD, San Keller, PhD, India Sisler, MD, Shirley Johnson, BA, Ding-Yu Fei, PhD, Daniel Sop Mouaffo, MS

Blood (2017) 130 (Supplement 1): 2258.

https://doi.org/10.1182/blood.V130.Suppl_1.2258.2258

Published: 2017

Journal Articles

Reducing Hospital Use of Urban Sickle Cell Adults Using Multidisciplinary Adult Care and Instrumental Support

Daniel Sop Mouaffo, MS, Wally R. Smith, MD, Zakiya Owens, PA-C, Thokozeni Lipato, MD, Marla Brannon, BS, Stefani Vaughan-Sams, Nyssa Towsley, BS, Ding-Yu Fei, PhD, Shirley Johnson, BA

Blood (2017) 130 (Supplement 1): 5661.

https://doi.org/10.1182/blood.V130.Suppl_1.5661.5661

Published: 2017

NARROW

COVID Symptoms and COVID Anxiety in Sickle Cell Disease

Early Initiation of Treatment with Rivipansel for Acute Vaso-Occlusive Crisis in Sickle Cell Disease (SCD) Achieves Earlier Discontinuation of IV Opioids and Shorter Hospital Stay: Reset Clinical Trial Analysis

The Effect of Crizanlizumab on the Number of Days Requiring Opioid Use for Management of Pain Associated with Vaso-Occlusive Crises in Patients with Sickle Cell Disease: Results from the Sustain Trial

Improvement in the Clinical Global Impression of Change with Voxelotor in Patients with Sickle Cell Disease in the Phase 3 HOPE Trial

Improved Utilization Amongst Adult Sickle Cell Disease Patients: A Multi-Disciplinary Medical Home Approach

Severity Classification for Sickle Cell Disease: A RAND/UCLA Modified Delphi Panel

Development and Validation of a Functional Status-Based Pain Assessment Tool

The Effect of Patient Navigators on Health-Related Quality of Life in Sickle Cell Anemia: The SHIP-HU Study

Case Management Featuring Community Health Workers Reduces Inpatient Health Care Utilization in Adults with Sickle Cell Disease

Tiered Oral Therapy Protocol for Sickle Cell Vaso-Occlusive Crisis

Using Lean Six Sigma to Develop a Patient Centered Medical Home for Adults with Sickle Cell Disease

Crizanlizumab Versus Placebo, with or without Hydroxyurea/Hydroxycarbamide, in Adolescent and Adult Patients with Sickle Cell Disease and Vaso-Occlusive Crises: A Randomized, Double-Blind, Phase III Study (STAND)

Responsivity of Utilization Rates to the Intensity of Case Management over Time Among High-Utilizing Adults with Sickle Cell Disease

The Effect of Patient Navigators on Laboratory Parameters of Hydroxyurea Adherence in Sickle Cell Anemia: The SHIP-HU Study

The Association of Painful Crises with Patient Reported Outcomes in Sickle Cell Disease: The SHIP-HU Study

Defining Sickle Cell Disease Acute Painful Episodes: The Pisces Project

Development of a Framework to Describe Roles and Responsibilities for Sickle Cell Community Health Workers

Access to Care, and Emergency Department Utilization for Adults and Adolescents with Sickle Cell Disease: Ascq-Me and the SHIP-HU Study

Comparison of Adult and Adolescent Quality of Ambulatory and Emergency Care in Sickle Cell Disease: Ascq-Me and the SHIP-HU Study

Reducing Hospital Use of Urban Sickle Cell Adults Using Multidisciplinary Adult Care and Instrumental Support

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only